Hualan Biological Vaccine Balance Sheet Health
Financial Health criteria checks 5/6
Hualan Biological Vaccine has a total shareholder equity of CN¥6.1B and total debt of CN¥300.0M, which brings its debt-to-equity ratio to 4.9%. Its total assets and total liabilities are CN¥7.6B and CN¥1.5B respectively. Hualan Biological Vaccine's EBIT is CN¥444.9M making its interest coverage ratio -5.3. It has cash and short-term investments of CN¥2.5B.
Key information
4.9%
Debt to equity ratio
CN¥300.00m
Debt
| Interest coverage ratio | -5.3x |
| Cash | CN¥2.54b |
| Equity | CN¥6.09b |
| Total liabilities | CN¥1.55b |
| Total assets | CN¥7.64b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 301207's short term assets (CN¥4.6B) exceed its short term liabilities (CN¥1.5B).
Long Term Liabilities: 301207's short term assets (CN¥4.6B) exceed its long term liabilities (CN¥44.2M).
Debt to Equity History and Analysis
Debt Level: 301207 has more cash than its total debt.
Reducing Debt: 301207's debt to equity ratio has increased from 0% to 4.9% over the past 5 years.
Debt Coverage: 301207's debt is well covered by operating cash flow (250%).
Interest Coverage: 301207 earns more interest than it pays, so coverage of interest payments is not a concern.